CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
The Company’s products are custom, patent-protected configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient’s blood system. The Company is initially focused on acute renal failure (ARF).
Past Team (3)Update
Funding Rounds (3) - $47.7MUpdate
Charter Oak Equity invests in niche manufacturing, packaging, medical products & services,...
North Coast's capitalization allows them to see a promising venture through all stages of...
Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to...
Lurie Investment Fund is the venture capital arm of the Ann and Robert H. Lurie Foundation...
Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical...
Life Sciences Investment Firm
Healthcare Investment Group
Ann Arbor, MI